amino acid disorders + urea cycle disorders + lipid disorders Flashcards

1
Q

amino acid disorders discussed in this class

A

phenylketonuria (PKU)

maple syrup urine disease (MUSD)

alkaptonuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PKU inheritance + general

A

autosomal recessive

impaired ability to metabolize phenylalanine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

PKU genetic abnormality

A

mutations involving loci encoding for PAH on chromosome 12q

mutations include substitutions, insertions, deletions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PKU

enzyme affected

A

phenylalanine hydroxylase (PAH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

PKU

effect on substrate/byproduct

A

buildup of phenylalanine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

PKU

pathophys

A

elevated levels of plasma phenylalanine that disrupts essentail cellular proccesses in the brain and eventually causes mental retardation

PKU levels of phenylalanine are 6-80 mg/dl (normal is 1 mg/dl)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

PKU

clinical manifestations

A

untreated PKU has severe mental retardation

normal at birth then progressive developmetnaly delay

must catch early and control

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

PKU

expression/penetrance

A

disease freq. varies by population

turkey has high incidence rate

high in yeminite jewish populaiton, northern/eastern europe, italy, and china

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

PKU treatment

A

restoring normal blood phe levels thru restricting dietary phe

strong relationship exists between control of blood phe levels in childhood and IQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

rare autosomal recessive diorder that involves defects in catabolic pathway of branched chain amino acids

A

maple syrup urine disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MUSD

genetic abnormality

A

caused by mutaiton of 1 of 6 loci that envode for the branched chain amino acid complex (BCKAD complex)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

BCKAD complex

A

composed of 4 catalytic components and 2 regulatory enzymes

most mutations occur in the catalytic compenent section

normally involved in decarboxylation of alpha keto acids of branched chain AAs to their acyl-CoA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MUSD

enzyme affected

A

BCKAD Complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

branched chain amino acids

A

leucine, isoleucine, valine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

effect on substrate/byproduct

MUSD

A

accumulation of branched chain amino acids (valine, leucine, isoleucine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

leucine accumulation

A

neurological symptoms bc it is transported rapidly across BBB and metabolized to yield presumably glutamate and glutamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

elevation of plasma isoleucine…

A

maple syrup odor of urine

18
Q

clinical manifestation of MSUD

A

accumulation of any of the 3 AA leads to encephalopathy and progressive neurodegeneration in infants not treated

poor feeding, vomiting, failure to thrive, increased lethargy

19
Q

MSUD expression and prevalance

A

more prevalant in populations with high frequency of consanguinity

ex. mennonite community of Lancaster County, PA

symptoms devleop in neonates aged 4-7 days

variability

20
Q

MSUD

treatment

A

early diagnosis and diet intervention to prevent complications and allow normal IQ

dietary restriction of branched chain AAs to only what is minimally needed

thiamine supplement

21
Q

Alkapotnuria

Genetic abnormality

A

HGO gene

defect in catabolic pathway of tyrosine

22
Q

intermediate product of tyrosine catabolic pathway

A

homogentisic acid

23
Q

Alkapotnuria

enzyme affected

A

deficiency of HGO

24
Q

Alkapotnuria

effect on substrate/byproduct

A

deficiency of HGO causes accumulation of homogentisic acid

homogentisic acid is rapidly cleared in kidney and excreted

25
Alkapotnuria
Plasma homogentisic acid is originally low due to rapid kidney clearence *however* w/time it is *depostited in cartilage throughout the body* resulting in a build up of dark pigment (**onchronosis**) normally transparent tissues will become slate blue
26
Alkaptonuria clincial manifestations
upon contact with open air, homogentisic acid is ozidized to form a pigment like polymeric material causes the **black color of standing urine** by 4th decade, tissues are slate blue *arthritis* (spine, lrg joints)
27
Alkaptonuria expression
HGO shows a wide spectrum of mutation with high variability
28
Alkaptonuria treatment
redution of Phe and Tyr reduces homogentisic acid excretion vitamin C supplement for older children and adults to reduce cartilage deposits
29
urea cycle disorder discussed in this class
orinthine transcarbamylase deficiency
30
orinthine transcarbamylase deficiency inheritance
X linked disorder (mostly in males, not females bc of X-inactivation)
31
orinthine transcarbamylase deficiency enzyme
**orinthine transcarbamylase** deficiency used in urea cycle to detoxify and excrete nitrogen
32
orinthine transcarbamylase deficiency clincial manifestations
excess nitrogen causing **severe hyperammonemia** in neonate (24-48 hrs after ingesting protein) progressive lethargy and decreased levels of conciousness Ias nitrogen levels increase) symptomatic females may displat headache or vomiting after consuming high protein meals and learning diabilities
33
orinthine transcarbamylase deficiency expression/penetrance
primary affects males females be symptomatic
34
orinthine transcarbamylase deficiency treatment
early, aggresive IV fluid, glucose, benzoic acid, penylacetate **high risk of recurrent hyperammonemia**
35
lipid disorder discussed in this class
medium chain acyl-CoA Dehydrogenase (MCAD)
36
most common fatty acid metabolic disorder
medium chain acyl-CoA dehydrogenase (MCAD)
37
MCAD genetic abnormality
results from deficiency of medium chain acyl-coenzyme A dehydrogenase
38
enzyme affected MCAD
medium chain -acyl coenzyme A dehydrogenase
39
MCAD effect on substrate/byproduct
fasting results in **accumulation of fatty acid intermediates and exhausts gluclose supply**
40
MCAD clinicla manifestations
**episodic hypoglycemia** *often provoked by fasting* may have vomiting and lethargy following fasting in children cerebal edema and encephalopathy
41
MCAD treatment
support during times of nutritional stress eat enough calories and avoid fasting